Brain Metastases

Neurologic Clinics

Volumn 25, Issue 4, 2007, Pages 1173-1192

  Nguyen, Teri D ^a   DeAngelis, Lisa M ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAPECITABINE; CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; FLUOROURACIL; FOLINIC ACID; FOTEMUSTINE; GEFITINIB; GEMCITABINE; IFOSFAMIDE; IRINOTECAN; LOMUSTINE; METHOTREXATE; NAVELBINE; PREDNISONE; TEMOZOLOMIDE; TENIPOSIDE; THALIDOMIDE; TOPOTECAN; VINCRISTINE;

BRAIN DISEASE; BRAIN METASTASIS; BRAIN SURGERY; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; COMPUTER ASSISTED TOMOGRAPHY; HUMAN; LEPTOMENINGEAL DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; REVIEW; STEREOTAXIC SURGERY; WHOLE BRAIN RADIATION THERAPY;

ANTINEOPLASTIC AGENTS; BRAIN NEOPLASMS; HUMANS; MAGNETIC RESONANCE IMAGING; NEUROSURGICAL PROCEDURES; RADIOSURGERY;

EID: 35348999439     PISSN: 07338619     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ncl.2007.07.011     Document Type: Review

References (81)

1. Landis S.H., Murray T., Bolden S., et al. Cancer statistics, 1999. CA Cancer J Clin 49 1 (1999) 8-31 31
2. DiStefano A., Yong Yap Y., Hortobagyi G.N., et al. The natural history of breast cancer patients with brain metastases. Cancer 44 5 (1979) 1913-1918
3. Markesbery W.R., Brooks W.H., Gupta G.D., et al. Treatment for patients with cerebral metastases. Arch Neurol 35 11 (1978) 754-756
4. Chason J.L., Walker F.B., and Landers J.W. Metastatic carcinoma in the central nervous system and dorsal root ganglia. A prospective autopsy study. Cancer 16 (1963) 781-787
5. Hunter K.M., and Newcastle N.B. Metastatic neoplasms of the brain stem. Can Med Assoc J 98 1 (1968) 1-7
6. Posner J.B., and Chernik N.L. Intracranial metastases from systemic cancer. Adv Neurol 19 (1978) 579-592
7. Nussbaum E.S., Djalilian H.R., Cho K.H., et al. Brain metastases. Histology, multiplicity, surgery, and survival. Cancer 78 8 (1996) 1781-1788
8. Zimm S., Wampler G.L., Stablein D., et al. Intracerebral metastases in solid-tumor patients: natural history and results of treatment. Cancer 48 2 (1981) 384-394
9. Graf A.H., Buchberger W., Langmayr H., et al. Site preference of metastatic tumours of the brain. Virchows Arch A Pathol Anat Histopathol 412 5 (1988) 493-498
10. Gabos Z., Sinha R., Hanson J., et al. Prognostic significance of human epidermal growth factor receptor positivity for the development of brain metastasis after newly diagnosed breast cancer. J Clin Oncol 24 36 (2006) 5658-5663
11. Sierra A., Price J.E., Garcia-Ramirez M., et al. Astrocyte-derived cytokines contribute to the metastatic brain specificity of breast cancer cells. Lab Invest 77 4 (1997) 357-368
12. Sze G., Milano E., Johnson C., et al. Detection of brain metastases: comparison of contrast-enhanced MR with unenhanced MR and enhanced CT. AJNR Am J Neuroradiol 11 4 (1990) 785-791
13. Maluf F.C., DeAngelis L.M., Raizer J.J., et al. High-grade gliomas in patients with prior systemic malignancies. Cancer 94 12 (2002) 3219-3224
14. Patchell R.A., Tibbs P.A., Walsh J.W., et al. A randomized trial of surgery in the treatment of single metastases to the brain. N Engl J Med 322 8 (1990) 494-500
15. Straathof C.S., de Bruin H.G., Dippel D.W., et al. The diagnostic accuracy of magnetic resonance imaging and cerebrospinal fluid cytology in leptomeningeal metastasis. J Neurol 246 9 (1999) 810-814
16. Wasserstrom W.R., Glass J.P., and Posner J.B. Diagnosis and treatment of leptomeningeal metastases from solid tumors: experience with 90 patients. Cancer 49 4 (1982) 759-772
17. Glantz M.J., Cole B.F., Forsyth P.A., et al. Practice parameter: anticonvulsant prophylaxis in patients with newly diagnosed brain tumors. Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 54 10 (2000) 1886-1893
18. Miller K.D., Weathers T., Haney L.G., et al. Occult central nervous system involvement in patients with metastatic breast cancer: prevalence, predictive factors and impact on overall survival. Ann Oncol 14 7 (2003) 1072-1077
19. Amer M.H. Chemotherapy and pattern of metastases in breast cancer patients. J Surg Oncol 19 2 (1982) 101-105
20. Hagemeister Jr. F.B., Buzdar A.U., Luna M.A., et al. Causes of death in breast cancer: a clinicopathologic study. Cancer 46 1 (1980) 162-167
21. Tsukada Y., Fouad A., Pickren J.W., et al. Central nervous system metastasis from breast carcinoma. Autopsy study. Cancer 52 12 (1983) 2349-2354
22. Gaspar L., Scott C., Rotman M., et al. Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials. Int J Radiat Oncol Biol Phys 37 4 (1997) 745-751
23. Gaspar L.E., Scott C., Murray K., et al. Validation of the RTOG recursive partitioning analysis (RPA) classification for brain metastases. Int J Radiat Oncol Biol Phys 47 4 (2000) 1001-1006
24. Borgelt B., Gelber R., Kramer S., et al. The palliation of brain metastases: final results of the first two studies by the Radiation Therapy Oncology Group. Int J Radiat Oncol Biol Phys 6 1 (1980) 1-9
25. Horton J., Baxter D.H., and Olson K.B. The management of metastases to the brain by irradiation and corticosteroids. Am J Roentgenol Radium Ther Nucl Med 111 2 (1971) 334-336
26. Kurtz J.M., Gelber R., Brady L.W., et al. The palliation of brain metastases in a favorable patient population: a randomized clinical trial by the Radiation Therapy Oncology Group. Int J Radiat Oncol Biol Phys 7 7 (1981) 891-895
27. Pease N.J., Edwards A., and Moss L.J. Effectiveness of whole brain radiotherapy in the treatment of brain metastases: a systematic review. Palliat Med 19 4 (2005) 288-299
28. DeAngelis L.M., Mandell L.R., Thaler H.T., et al. The role of postoperative radiotherapy after resection of single brain metastases. Neurosurgery 24 6 (1989) 798-805
29. Cooper J.S., Steinfeld A.D., and Lerch I.A. Cerebral metastases: value of reirradiation in selected patients. Radiology 174 3 Pt 1 (1990) 883-885
30. Hazuka M.B., and Kinzie J.J. Brain metastases: results and effects of re-irradiation. Int J Radiat Oncol Biol Phys 15 2 (1988) 433-437
31. Kurup P., Reddy S., and Hendrickson F.R. Results of re-irradiation for cerebral metastases. Cancer 46 12 (1980) 2587-2589
32. Shehata W.M., Hendrickson F.R., and Hindo W.A. Rapid fractionation technique and re-treatment of cerebral metastases by irradiation. Cancer 34 2 (1974) 257-261
33. Wong W.W., Schild S.E., Sawyer T.E., et al. Analysis of outcome in patients reirradiated for brain metastases. Int J Radiat Oncol Biol Phys 34 3 (1996) 585-590
34. Vecht C.J., Haaxma-Reiche H., Noordijk E.M., et al. Treatment of single brain metastasis: radiotherapy alone or combined with neurosurgery?. Ann Neurol 33 6 (1993) 583-590
35. Mintz A.H., Kestle J., Rathbone M.P., et al. A randomized trial to assess the efficacy of surgery in addition to radiotherapy in patients with a single cerebral metastasis. Cancer 78 7 (1996) 1470-1476
36. Patchell R.A., Tibbs P.A., Regine W.F., et al. Postoperative radiotherapy in the treatment of single metastases to the brain: a randomized trial. JAMA 280 17 (1998) 1485-1489
37. Andrews D.W., Scott C.B., Sperduto P.W., et al. Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial. Lancet 363 9422 (2004) 1665-1672
38. Aoyama H., Shirato H., Tago M., et al. Stereotactic radiosurgery plus whole-brain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases: a randomized controlled trial. JAMA 295 21 (2006) 2483-2491
39. Boogerd W., Dalesio O., Bais E.M., et al. Response of brain metastases from breast cancer to systemic chemotherapy. Cancer 69 4 (1992) 972-980
40. Rivera E., Meyers C., Groves M., et al. Phase I study of capecitabine in combination with temozolomide in the treatment of patients with brain metastases from breast carcinoma. Cancer 107 6 (2006) 1348-1354
41. Lassman A.B., Abrey L.E., Shah G.D., et al. Systemic high-dose intravenous methotrexate for central nervous system metastases. J Neurooncol 78 3 (2006) 255-260
42. Christodoulou C., Bafaloukos D., Linardou H., et al. Temozolomide (TMZ) combined with cisplatin (CDDP) in patients with brain metastases from solid tumors: a Hellenic Cooperative Oncology Group (HeCOG) phase II study. J Neurooncol 71 1 (2005) 61-65
43. Ceresoli G.L., Cappuzzo F., Gregorc V., et al. Gefitinib in patients with brain metastases from non-small-cell lung cancer: a prospective trial. Ann Oncol 15 7 (2004) 1042-1047
44. Hotta K., Kiura K., Ueoka H., et al. Effect of gefitinib ('Iressa', ZD1839) on brain metastases in patients with advanced non-small-cell lung cancer. Lung Cancer 46 2 (2004) 255-261
45. Namba Y., Kijima T., Yokota S., et al. Gefitinib in patients with brain metastases from non-small-cell lung cancer: review of 15 clinical cases. Clin Lung Cancer 6 2 (2004) 123-128
46. Giorgio C.G., Giuffrida D., Pappalardo A., et al. Oral temozolomide in heavily pre-treated brain metastases from non-small cell lung cancer: phase II study. Lung Cancer 50 2 (2005) 247-254
47. Boogerd W., van der Sande J.J., and van Zandwijk N. Teniposide sometimes effective in brain metastases from non-small cell lung cancer. J Neurooncol 41 3 (1999) 285-289
48. Abrey L.E., Olson J.D., Raizer J.J., et al. A phase II trial of temozolomide for patients with recurrent or progressive brain metastases. J Neurooncol 53 3 (2001) 259-265
49. Kaba S.E., Kyritsis A.P., Hess K., et al. TPDC-FuHu chemotherapy for the treatment of recurrent metastatic brain tumors. J Clin Oncol 15 3 (1997) 1063-1070
50. Omuro A.M., Raizer J.J., Demopoulos A., et al. Vinorelbine combined with a protracted course of temozolomide for recurrent brain metastases: a phase I trial. J Neurooncol 78 3 (2006) 277-280
51. Caraglia M., Addeo R., Costanzo R., et al. Phase II study of temozolomide plus pegylated liposomal doxorubicin in the treatment of brain metastases from solid tumours. Cancer Chemother Pharmacol 57 1 (2006) 34-39
52. Korfel A., Oehm C., von Pawel J., et al. Response to topotecan of symptomatic brain metastases of small-cell lung cancer also after whole-brain irradiation. A multicentre phase II study. Eur J Cancer 38 13 (2002) 1724-1729
53. Hwu W.J., Lis E., Menell J.H., et al. Temozolomide plus thalidomide in patients with brain metastases from melanoma: a phase II study. Cancer 103 12 (2005) 2590-2597
54. Jacquillat C., Khayat D., Banzet P., et al. Final report of the French multicenter phase II study of the nitrosourea fotemustine in 153 evaluable patients with disseminated malignant melanoma including patients with cerebral metastases. Cancer 66 9 (1990) 1873-1878
55. Rosner D., Nemoto T., and Lane W.W. Chemotherapy induces regression of brain metastases in breast carcinoma. Cancer 58 4 (1986) 832-839
56. Oberhoff C., Kieback D.G., Wurstlein R., et al. Topotecan chemotherapy in patients with breast cancer and brain metastases: results of a pilot study. Onkologie 24 3 (2001) 256-260
57. Franciosi V., Cocconi G., Michiara M., et al. Front-line chemotherapy with cisplatin and etoposide for patients with brain metastases from breast carcinoma, nonsmall cell lung carcinoma, or malignant melanoma: a prospective study. Cancer 85 7 (1999) 1599-1605
58. Agarwala S.S., Kirkwood J.M., Gore M., et al. Temozolomide for the treatment of brain metastases associated with metastatic melanoma: a phase II study. J Clin Oncol 22 11 (2004) 2101-2107
59. Boogerd W., de Gast G.C., and Dalesio O. Temozolomide in advanced malignant melanoma with small brain metastases: can we withhold cranial irradiation?. Cancer 109 2 (2007) 306-312
60. Fujita A., Fukuoka S., Takabatake H., et al. Combination chemotherapy of cisplatin, ifosfamide, and irinotecan with rhG-CSF support in patients with brain metastases from non-small cell lung cancer. Oncology 59 4 (2000) 291-295
61. Minotti V., Crino L., Meacci M.L., et al. Chemotherapy with cisplatin and teniposide for cerebral metastases in non-small cell lung cancer. Lung Cancer 20 2 (1998) 93-98
62. Bernardo G., Cuzzoni Q., Strada M.R., et al. First-line chemotherapy with vinorelbine, gemcitabine, and carboplatin in the treatment of brain metastases from non-small-cell lung cancer: a phase II study. Cancer Invest 20 3 (2002) 293-302
63. Colleoni M., Graiff C., Nelli P., et al. Activity of combination chemotherapy in brain metastases from breast and lung adenocarcinoma. Am J Clin Oncol 20 3 (1997) 303-307
64. Vinolas N., Graus F., Mellado B., et al. Phase II trial of cisplatinum and etoposide in brain metastases of solid tumors. J Neurooncol 35 2 (1997) 145-148
65. Lorusso V., Galetta D., Giotta F., et al. Topotecan in the treatment of brain metastases. A phase II study of GOIM (Gruppo Oncologico dell'Italia Meridionale). Anticancer Res 26 3B (2006) 2259-2263
66. Tummarello D., Lippe P., Bracci R., et al. First line chemotherapy in patients with brain metastases from non-small and small cell lung cancer. Oncol Rep 5 4 (1998) 897-900
67. Malacarne P., Santini A., and Maestri A. Response of brain metastases from lung cancer to systemic chemotherapy with carboplatin and etoposide. Oncology 53 3 (1996) 210-213
68. Seute T., Leffers P., Wilmink J.T., et al. Response of asymptomatic brain metastases from small-cell lung cancer to systemic first-line chemotherapy. J Clin Oncol 24 13 (2006) 2079-2083
69. Kollmannsberger C., Nichols C., Bamberg M., et al. First-line high-dose chemotherapy +/- radiation therapy in patients with metastatic germ-cell cancer and brain metastases. Ann Oncol 11 5 (2000) 553-559
70. Cocconi G., Lottici R., Bisagni G., et al. Combination therapy with platinum and etoposide of brain metastases from breast carcinoma. Cancer Invest 8 3-4 (1990) 327-334
71. Verger E., Gil M., Yaya R., et al. Temozolomide and concomitant whole brain radiotherapy in patients with brain metastases: a phase II randomized trial. Int J Radiat Oncol Biol Phys 61 1 (2005) 185-191
72. Robinet G., Thomas P., Breton J.L., et al. Results of a phase III study of early versus delayed whole brain radiotherapy with concurrent cisplatin and vinorelbine combination in inoperable brain metastasis of non-small-cell lung cancer: Groupe Francais de Pneumo-Cancerologie (GFPC) Protocol 95-1. Ann Oncol 12 1 (2001) 59-67
73. Guerrieri M., Wong K., Ryan G., et al. A randomised phase III study of palliative radiation with concomitant carboplatin for brain metastases from non-small cell carcinoma of the lung. Lung Cancer 46 1 (2004) 107-111
74. Cortot A.B., Geriniere L., Robinet G., et al. Phase II trial of temozolomide and cisplatin followed by whole brain radiotherapy in non-small-cell lung cancer patients with brain metastases: a GLOT-GFPC study. Ann Oncol 17 9 (2006) 1412-1417
75. Pronzato P., Bruna F., Neri E., et al. Radiotherapy plus carboplatin and teniposide in patients with brain metastases from non small cell lung cancer. Anticancer Res 15 2 (1995) 517-519
76. Moscetti L., Nelli F., Felici A., et al. Up-front chemotherapy and radiation treatment in newly diagnosed nonsmall cell lung cancer with brain metastases: survey by Outcome Research Network for Evaluation of Treatment Results in Oncology. Cancer 109 2 (2007) 274-281
77. Ushio Y., Arita N., Hayakawa T., et al. Chemotherapy of brain metastases from lung carcinoma: a controlled randomized study. Neurosurgery 28 2 (1991) 201-205
78. Postmus P.E., Haaxma-Reiche H., Smit E.F., et al. Treatment of brain metastases of small-cell lung cancer: comparing teniposide and teniposide with whole-brain radiotherapy-a phase III study of the European Organization for the Research and Treatment of Cancer Lung Cancer Cooperative Group. J Clin Oncol 18 19 (2000) 3400-3408
79. Paul M.J., Summers Y., Calvert A.H., et al. Effect of temozolomide on central nervous system relapse in patients with advanced melanoma. Melanoma Res 12 2 (2002) 175-178
80. Stea B., Suh J.H., Boyd A.P., et al. Whole-brain radiotherapy with or without efaproxiral for the treatment of brain metastases: determinants of response and its prognostic value for subsequent survival. Int J Radiat Oncol Biol Phys 64 4 (2006) 1023-1030
81. Meyers C.A., Smith J.A., Bezjak A., et al. Neurocognitive function and progression in patients with brain metastases treated with whole-brain radiation and motexafin gadolinium: results of a randomized phase III trial. J Clin Oncol 22 1 (2004) 157-165